The latest price target for Accelerate Diagnostics Inc COM NEW (NASDAQ:AXDX) was reported by Craig-Hallum on April 1, 2024. The analyst firm set a price target for $1.00 expecting AXDX to rise to within 12 months (a possible 1823.08% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Accelerate Diagnostics Inc COM NEW (NASDAQ:AXDX) was provided by Craig-Hallum, and Accelerate Diagnostics Inc COM NEW maintained their hold rating.

There is no last upgrade for Accelerate Diagnostics Inc COM NEW

There is no last downgrade for Accelerate Diagnostics Inc COM NEW.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Accelerate Diagnostics Inc COM NEW, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Accelerate Diagnostics Inc COM NEW was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.

While ratings are subjective and will change, the latest Accelerate Diagnostics Inc COM NEW (AXDX) rating was a maintained with a price target of $2.00 to $1.00. The current price Accelerate Diagnostics Inc COM NEW (AXDX) is trading at is $0.05, which is out of the analyst’s predicted range.